US OptionsDetailed Quotes
FTFT241220P5000
- 4.54
- 0.000.00%
15min DelayClose Nov 29 13:00 ET
0.00High0.00Low
4.54Open4.54Pre Close0 Volume1 Open Interest5.00Strike Price0.00Turnover0.00%IV-6.98%PremiumDec 20, 2024Expiry Date4.57Intrinsic Value100Multiplier19DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.09Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Future FinTech Stock Discussion
Sign in to post a comment
$Infobird Software (IFBD.US)$ $Future FinTech (FTFT.US)$ $Integrated Media Technology (IMTE.US)$ $Petros Pharmaceuticals (PTPI.US)$ $Bone Biologics (BBLG.US)$ $Nuburu (BURU.US)$ $Novocure (NVCR.US)$ $Ucommune International (UK.US)$ $Biodexa Pharmaceuticals (BDRX.US)$ $Carmell (CTCX.US)$ $Santech Holdings (STEC.US)$
1
1
Despite Future FinTech Group's recent share price climb, its P/S lags behind most companies. Its three-year revenue trends aren't boosting its P/S as expected, indicating potential underlying risks to its profitability, pressuring the P/S ratio.
SEC's allegations against Huang may harm Future FinTech's reputation and stock price. The regulator's barring of Huang from public company leadership could alter the company's future.
$Future FinTech (FTFT.US)$ finally you move haha
$Future FinTech (FTFT.US)$ no body wan buy this rubbish stock. all btc related stock rise. haha.
Future FinTech Group's weak revenue could fail to meet industry standards, causing a slump in its P/S ratio. This decline might point to future performance risks that shareholders are factoring into selling prices.
No comment yet
Den the Dragon :
